Argenx CEO to step down in May, be succeeded by COO Tim Van Hauwermeiren has led the Belgian drugmaker since 2008

https://www.statnews.com/2026/01/05/argenx-ceo-to-step-down-tim-van-hauwermeiren-karen-massey/ By Adam FeuersteinJan. 5, 2026 Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and biotechnology.